LMW Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 23, 2025, 9:17 am

Quick Insight

Lakshmi Machine Works Ltd, with a market capitalization of ₹18,510 Cr. and a share price of 17,325, is trading at a P/E ratio of 63.6, indicating a premium valuation. The company's ROE stands at 14.0%, while the ROCE is robust at 18.1%, reflecting efficient capital allocation. With a healthy OPM of 10% and a net profit of ₹384 Cr., Lakshmi Machine Works demonstrates operational strength. The significant promoter holding of 31.13% underscores confidence in the business. However, the low ICR of 0.00x raises concerns about the company's ability to meet its short-term obligations. Investors should closely monitor the company's profitability and liquidity position for potential risks.

Competitors of LMW Ltd

All Competitor Stocks of LMW Ltd

Quarterly Result

Last Updated: August 21, 2025, 1:58 pm

Below is a detailed analysis of the quarterly data for LMW Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 694.00 Cr.. The value appears to be declining and may need further review. It has decreased from 804.00 Cr. (Mar 2025) to 694.00 Cr., marking a decrease of 110.00 Cr..
• For Expenses, as of Jun 2025, the value is 680.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 746.00 Cr. (Mar 2025) to 680.00 Cr., marking a decrease of 66.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 58.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 44.00 Cr..
• For OPM %, as of Jun 2025, the value is 2.00%. The value appears to be declining and may need further review. It has decreased from 7.00% (Mar 2025) to 2.00%, marking a decrease of 5.00%.
• For Other Income, as of Jun 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Mar 2025) to 35.00 Cr., marking an increase of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 41.00 Cr..
• For Tax %, as of Jun 2025, the value is 41.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Mar 2025) to 41.00%, marking an increase of 19.00%.
• For Net Profit, as of Jun 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 48.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 37.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 10.74. The value appears to be declining and may need further review. It has decreased from 44.76 (Mar 2025) to 10.74, marking a decrease of 34.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 21, 2025, 1:58 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 21, 2025, 1:58 pm

Below is a detailed analysis of the balance sheet data for LMW Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,767.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,693.00 Cr. (Mar 2024) to 2,767.00 Cr., marking an increase of 74.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,230.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,328.00 Cr. (Mar 2024) to 1,230.00 Cr., marking a decrease of 98.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 4,008.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,031.00 Cr. (Mar 2024) to 4,008.00 Cr., marking a decrease of 23.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 990.00 Cr.. The value appears strong and on an upward trend. It has increased from 972.00 Cr. (Mar 2024) to 990.00 Cr., marking an increase of 18.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 5.00 Cr..
• For Investments, as of Mar 2025, the value is 701.00 Cr.. The value appears strong and on an upward trend. It has increased from 641.00 Cr. (Mar 2024) to 701.00 Cr., marking an increase of 60.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,312.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,409.00 Cr. (Mar 2024) to 2,312.00 Cr., marking a decrease of 97.00 Cr..
• For Total Assets, as of Mar 2025, the value is 4,008.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,031.00 Cr. (Mar 2024) to 4,008.00 Cr., marking a decrease of 23.00 Cr..

Notably, the Reserves (2,767.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for LMW Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 96.05. This value is within the healthy range. It has decreased from 349.77 (Mar 24) to 96.05, marking a decrease of 253.72.
• For Diluted EPS (Rs.), as of Mar 25, the value is 96.05. This value is within the healthy range. It has decreased from 349.77 (Mar 24) to 96.05, marking a decrease of 253.72.
• For Cash EPS (Rs.), as of Mar 25, the value is 201.51. This value is within the healthy range. It has decreased from 440.07 (Mar 24) to 201.51, marking a decrease of 238.56.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,600.58. It has increased from 2,531.50 (Mar 24) to 2,600.58, marking an increase of 69.08.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,600.58. It has increased from 2,531.50 (Mar 24) to 2,600.58, marking an increase of 69.08.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,820.23. It has decreased from 4,396.87 (Mar 24) to 2,820.23, marking a decrease of 1,576.64.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 247.09. This value is within the healthy range. It has decreased from 541.67 (Mar 24) to 247.09, marking a decrease of 294.58.
• For PBIT / Share (Rs.), as of Mar 25, the value is 141.66. This value is within the healthy range. It has decreased from 451.46 (Mar 24) to 141.66, marking a decrease of 309.80.
• For PBT / Share (Rs.), as of Mar 25, the value is 141.66. This value is within the healthy range. It has decreased from 451.46 (Mar 24) to 141.66, marking a decrease of 309.80.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 96.08. This value is within the healthy range. It has decreased from 349.87 (Mar 24) to 96.08, marking a decrease of 253.79.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 96.08. This value is within the healthy range. It has decreased from 349.87 (Mar 24) to 96.08, marking a decrease of 253.79.
• For PBDIT Margin (%), as of Mar 25, the value is 8.76. This value is below the healthy minimum of 10. It has decreased from 12.31 (Mar 24) to 8.76, marking a decrease of 3.55.
• For PBIT Margin (%), as of Mar 25, the value is 5.02. This value is below the healthy minimum of 10. It has decreased from 10.26 (Mar 24) to 5.02, marking a decrease of 5.24.
• For PBT Margin (%), as of Mar 25, the value is 5.02. This value is below the healthy minimum of 10. It has decreased from 10.26 (Mar 24) to 5.02, marking a decrease of 5.24.
• For Net Profit Margin (%), as of Mar 25, the value is 3.40. This value is below the healthy minimum of 5. It has decreased from 7.95 (Mar 24) to 3.40, marking a decrease of 4.55.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.40. This value is below the healthy minimum of 8. It has decreased from 7.95 (Mar 24) to 3.40, marking a decrease of 4.55.
• For Return on Networth / Equity (%), as of Mar 25, the value is 3.69. This value is below the healthy minimum of 15. It has decreased from 13.82 (Mar 24) to 3.69, marking a decrease of 10.13.
• For Return on Capital Employeed (%), as of Mar 25, the value is 5.03. This value is below the healthy minimum of 10. It has decreased from 16.21 (Mar 24) to 5.03, marking a decrease of 11.18.
• For Return On Assets (%), as of Mar 25, the value is 2.56. This value is below the healthy minimum of 5. It has decreased from 9.26 (Mar 24) to 2.56, marking a decrease of 6.70.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.74. It has decreased from 1.16 (Mar 24) to 0.74, marking a decrease of 0.42.
• For Current Ratio (X), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from 2.15 (Mar 24) to 2.62, marking an increase of 0.47.
• For Quick Ratio (X), as of Mar 25, the value is 2.06. This value exceeds the healthy maximum of 2. It has increased from 1.56 (Mar 24) to 2.06, marking an increase of 0.50.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.04. This value is below the healthy minimum of 4. It has decreased from 4.46 (Mar 24) to 3.04, marking a decrease of 1.42.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 78.08. This value exceeds the healthy maximum of 50. It has increased from 28.16 (Mar 24) to 78.08, marking an increase of 49.92.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 37.22. This value is within the healthy range. It has increased from 22.38 (Mar 24) to 37.22, marking an increase of 14.84.
• For Earning Retention Ratio (%), as of Mar 25, the value is 21.92. This value is below the healthy minimum of 40. It has decreased from 71.84 (Mar 24) to 21.92, marking a decrease of 49.92.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 62.78. This value is within the healthy range. It has decreased from 77.62 (Mar 24) to 62.78, marking a decrease of 14.84.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Enterprise Value (Cr.), as of Mar 25, the value is 15,718.93. It has increased from 15,240.67 (Mar 24) to 15,718.93, marking an increase of 478.26.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.22. This value exceeds the healthy maximum of 3. It has increased from 3.25 (Mar 24) to 5.22, marking an increase of 1.97.
• For EV / EBITDA (X), as of Mar 25, the value is 59.57. This value exceeds the healthy maximum of 15. It has increased from 26.35 (Mar 24) to 59.57, marking an increase of 33.22.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.67. This value exceeds the healthy maximum of 3. It has increased from 3.45 (Mar 24) to 5.67, marking an increase of 2.22.
• For Retention Ratios (%), as of Mar 25, the value is 21.91. This value is below the healthy minimum of 30. It has decreased from 71.83 (Mar 24) to 21.91, marking a decrease of 49.92.
• For Price / BV (X), as of Mar 25, the value is 6.15. This value exceeds the healthy maximum of 3. It has increased from 5.99 (Mar 24) to 6.15, marking an increase of 0.16.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.67. This value exceeds the healthy maximum of 3. It has increased from 3.45 (Mar 24) to 5.67, marking an increase of 2.22.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness